Radiation synovectomy by intra-articular injection of p-emitting radionucli
des is a reliable and easy-to-perform therapy without harmful side effects
for the treatment of inflammatory rheumatoid as well as degenerative joint
diseases. The indication for radiation synovectomy is based on both clinica
l symptoms and on proven hyperperfusion, with active synovitis being seen o
n a pre-therapeutic three-phase bone scan. In this study, the clinical resp
onse after 6-18 months, evaluated by a standardized questionnaire, was comp
ared with the reduction of synovitis seen on three-phase bone scintigraphy
after treatment of 475 joints in 151 patients. The best clinical results we
re obtained in cases of true rheumatoid arthritis (73.4%), with less in oth
er kinds of arthritis (48.8%) such as psoriatic or reactive arthritis. Beca
use of the inflamed synovium being the main target tissue, clinical results
in osteoarthritis with severe bone destruction are poorer (33.9%). However
, synovitis can be markedly reduced (in approximately 70%), regardless of t
he underlying diagnosis, as shown by post-therapeutic three-phase bone scan
ning. Radiation synovectomy can be recommended in all kinds of arthritis. I
t should also be considered in cases of osteoarthritis as a last therapeuti
c option prior to joint replacement. ((C) 2001 Lippincott Williams & Wilkin
s).